This clinical trial is focused on studying the treatment of erysipelas, a skin infection that often affects the lower legs. The study will use a medication called amoxicillin, which is a type of antibiotic known as semi-synthetic penicillin. The purpose of the study is to determine if a shorter course of amoxicillin treatment, lasting 5 days, is as effective as the standard 10-day course in achieving complete recovery from erysipelas.

Participants in the study will be randomly assigned to receive either the short or standard course of amoxicillin. The treatment will be taken orally, meaning it is swallowed in pill form. The study will monitor the participants’ recovery over a period of time, checking for the disappearance of symptoms such as fever, pain, warmth, redness, and swelling at the site of the infection. The goal is to see if the shorter treatment is just as good at helping patients recover without needing additional antibiotics.

The study will also look at other factors, such as the rate of recurrence of the infection and any side effects experienced by participants during and after the treatment. This information will help determine the best treatment duration for erysipelas, potentially leading to shorter and more convenient treatment options for patients in the future.